Minneapolis Clinical Trials
2304 GBT021601
Purpose: to evaluate the safety and tolerability of a potential new drug for sickle cell disease and the difference in participants with kidney impairment compared to those with normal kidney function.
5 nights
7 visits
Participate in a clinical study of a potential treatment for sickle cell anemia.
This study has 1 screening appointment, 1 inpatient stay of 5 nights/ 6 days and 6 outpatient visits.
Reimbursement for study participation will be provided for time and travel of up to $5,800.
Transportation may be arranged to and from the Nucleus clinic for appointments.
This study has been reviewed by an independent ethics committee.
Call 612-315-6490 to discuss your eligibility today!
Eligibility
Age: 18 years or older
Weight: Greater than or equal to 110 lbs
Medication: Approved on case-by-case basis by medical monitor and pharmacists
Dose Administration: Oral dose
Compensation: Up to $5,800